Type of renal dysfunction affects liver cirrhosis mortality risk
September 4, 2019
Patients with acute on chronic kidney disease fared the worst.
Some HCV medications associated with serious liver injury
August 29, 2019
In many cases, the medications should never have been prescribed, according to the FDA.
Women survive more often than men do when hospitalized with cirrhosis
March 6, 2019
Women more often had infections and comorbidities, while men more often had liver decompensation, which contributed most significantly to their higher mortality rate.
Length of stay, complications predict readmission for cirrhosis patients
October 25, 2018
PHILADELPHIA – Patients with cirrhosis have a higher risk of hospital readmission if their length of stay is less than 4 days, if they have cirrhosis-related complications, and if they are discharged to an extended-care facility or to home health care, according to a recent presentation at the annual meeting of the American College of Gastroenterology.
Primary cirrhotic prophylaxis of bacterial peritonitis falls short
July 9, 2018
A review of prospective data from 308 cirrhotic patients on antibiotic prophylaxis highlights the limitations of this treatment.
FDA approves Doptelet for liver disease patients undergoing procedures
May 22, 2018
Avatrombopag (Doptelet) is the first drug approved for thrombocytopenia in adults who have chronic liver disease and are undergoing a procedure.
Class III obesity increases risk of acute on chronic liver failure in cirrhotic patients
May 6, 2018
Patients with a BMI greater than or equal to 40 kg/m2 with decompensated cirrhosis are at greater risk of developing acute on chronic liver failure.
Psychiatric issues common among hepatitis C inpatients
February 6, 2018
Comorbidities like drug abuse and psychoses present much more often in those with hepatitis C.
Carvedilol fails to reduce variceal bleeds in acute-on-chronic liver failure
October 24, 2017
Some improvement seen at 28 days in acute kidney injury, sepsis.
VIDEO: Meta-analysis favors anticoagulation for patients with cirrhosis and portal vein thrombosis
July 5, 2017
Anticoagulation has significant benefits and does not increase bleeding risk, regardless of the severity of liver failure.